Gene: TBC1D16
Official Full Name: TBC1 domain family member 16provided by HGNC
Gene Summary: Enables GTPase activator activity. Involved in regulation of receptor recycling. Located in cytosol and early endosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27756 | TBC1D16 Knockout cell line (HeLa) | Human | TBC1D16 | 1:3~1:6 | Negative | Online Inquiry |
KO27757 | TBC1D16 Knockout cell line (HCT 116) | Human | TBC1D16 | 1:2~1:4 | Negative | Online Inquiry |
KO27758 | TBC1D16 Knockout cell line (HEK293) | Human | TBC1D16 | 1:3~1:6 | Negative | Online Inquiry |
KO27759 | TBC1D16 Knockout cell line (A549) | Human | TBC1D16 | 1:3~1:4 | Negative | Online Inquiry |
TBC1D16 Gene Knockout Cell Lines are genetically engineered models designed to facilitate the study of TBC1D16, a gene implicated in intracellular trafficking and regulation of glucose homeostasis. These knockout cell lines feature precise deletions of the TBC1D16 gene, allowing researchers to investigate the functional consequences of its absence and contribute to a deeper understanding of various biological processes, particularly those related to metabolic regulation and vesicular transport.
The primary mechanism of TBC1D16 involves its role as a GTPase-activating protein (GAP) for specific Rabs, crucial in mediating the dynamics of intracellular vesicles. By disrupting this gene, these knockout cell lines reveal insights into the pathways associated with glucose uptake and insulin signaling, making them invaluable in metabolic research and diabetes studies. Researchers can use these models to elucidate the biological implications of TBC1D16 in both normal physiology and disease states, enabling the development of targeted therapeutic strategies.
In comparison to alternative models, such as wild-type or overexpressing cell lines, the TBC1D16 knockout cell lines provide a clearer and more informative picture of gene function by eliminating potential confounding effects. This specificity makes them a unique tool for examining gene function in a controlled environment.
For researchers and clinicians focused on metabolic disorders, TBC1D16 Gene Knockout Cell Lines present an unmatched opportunity to explore the roles of this gene in depth, paving the way for breakthroughs in treatment modalities. Additionally, these cell lines are developed using rigorous protocols by our team, who possess extensive expertise in genetic engineering and cell biology, ensuring robust, reproducible results to enhance your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.